Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.4K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

687
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
687
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.4K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.4K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

2.0K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The LTI-01-2001 phase 2a trial of intrapleural LTI-01 in patients with infected, non-draining pleural effusions.

Respiratory research·2026
Same author

Extracranial Spread of Meningiomas: Molecular Determinants, Diagnostic Pathways, and Lessons From Three Thoracic Metastases.

Cureus·2026
Same author

Airway-Predominant Mucous Membrane Pemphigoid Causing Recurrent Central Airway Obstruction: A Fatal Case and Review of Interventional Management.

Cureus·2026
Same author

Population-Based Evidence of Familial Clustering in Pulmonary Carcinoid Tumors: Insights From the Utah Population Database.

Cureus·2025
Same author

Aerosol Generation During Bronchoscopy.

Journal of bronchology & interventional pulmonology·2023
Same author

Effects of COVID-19 restriction measures in Indonesia: A comparative spatial and policy analysis of selected urban agglomerations.

International journal of disaster risk reduction : IJDRR·2022

Related Experiment Video

Updated: Mar 19, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K

Respiratory Complication in Liver Disease.

Vijaya S Ramalingam1, Sikandar Ansari2, Micah Fisher3

  • 1Division of Pulmonary & Critical Care Medicine, Department of Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA.

Critical Care Clinics
|June 25, 2016
PubMed
Summary

Cirrhosis patients experiencing shortness of breath may have serious lung complications. Early evaluation for hepatopulmonary syndrome, hepatic hydrothorax, and portopulmonary hypertension is crucial for managing liver disease outcomes.

Keywords:
Chronic liver diseaseHepatic hydrothoraxHepatopulmonary syndromeLiver transplantationPortopulmonary hypertensionSpontaneous bacterial pleuritis

More Related Videos

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.4K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

666

Related Experiment Videos

Last Updated: Mar 19, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

2.4K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

666

Area of Science:

  • Medicine
  • Hepatology
  • Pulmonology

Background:

  • Cirrhosis is a major cause of death in the US.
  • Liver disease frequently leads to pulmonary complications.
  • Key complications include hepatopulmonary syndrome, hepatic hydrothorax, and portopulmonary hypertension.

Purpose of the Study:

  • To review the significant pulmonary complications of cirrhosis.
  • To highlight the importance of evaluating dyspnea in cirrhosis patients.

Main Methods:

  • Review of existing literature on cirrhosis-related pulmonary complications.
  • Clinical assessment guidelines for patients with cirrhosis and dyspnea.

Main Results:

  • Hepatopulmonary syndrome, hepatic hydrothorax, and portopulmonary hypertension are critical complications.
  • Dyspnea in cirrhosis patients warrants investigation for these conditions.

Conclusions:

  • Pulmonary complications significantly impact morbidity and mortality in cirrhosis.
  • Timely diagnosis and management of these complications are essential for patient care.